Zimbabwe unveils its cannabis cultivation licenses
The Zimbabwean government has announced the three licenses that will allow, among other things, the cultivation of cannabis under the auspices of the’Agricultural Marketing Authority (AMA), the regulatory authority responsible for cannabis.
The Zimbabwe has legalized cannabis production for medical and scientific purposes in April 2018. The country announced last year that 37 local and private investors had expressed interest in growing cannabis.
This year, a policy change was implemented allowing investors to hold 100% medical cannabis licenses in order to enhance the sector’s competitiveness at both the regional and global levels. The AMA can now issue licenses granting the right to cultivate medical cannabis.
«The Authority may issue the following types of permits: a general grower’s permit, a research and breeding, »…and a commercial hemp license," according to Zimbabwean regulations.
A general grower's license authorizes the license holder to grow, process, and sell cannabis. The license may be restricted to specific varieties or apply only to industrial hemp.
The research and selection license allows for the cultivation of specific cultivars and varieties that are not approved for commercial cultivation.
A cannabis license allows the holder to sell cannabis in Zimbabwe. The cultivation of cannabis and related trade are permitted in Zimbabwe solely for medical and industrial purposes.
The use of cannabis remains illegal in Zimbabwe, and most commercial activities related to cannabis are prohibited from advertising.
-
Cannabis in Africa1 week ago
Nigeria moves a step closer to legalizing medical cannabis
-
Cannabis in France1 week ago
Le Champ d’en Face aims to bring hemp back into the public discourse
-
Cannabis in France1 week ago
French CBD industry to challenge CBD product control plan in court
-
Cannabis in the Caribbean1 week ago
Antigua and Barbuda: When Cannabis Becomes a Cultural Destination and a Tool for Sovereignty
-
Business3 days ago
Europe authorizes the first cannabis-derived medicine for the treatment of chronic pain
-
Cannabinoids1 week ago
Japan bans CBN
-
Business1 week ago
Germany imported over 50 tonnes of medical cannabis in the first quarter of 2026
-
Cannabis in the U.S.1 week ago
Trump's reclassification of cannabis is being challenged in court


You must be logged in to post a comment Login